The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis.
about
Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease.Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches.Obesity and nonalcoholic fatty liver disease: current perspectivesAdapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease
P2860
The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The new-generation pan-peroxis ...... abolic disorders and fibrosis.
@en
The new-generation pan-peroxis ...... abolic disorders and fibrosis.
@nl
type
label
The new-generation pan-peroxis ...... abolic disorders and fibrosis.
@en
The new-generation pan-peroxis ...... abolic disorders and fibrosis.
@nl
prefLabel
The new-generation pan-peroxis ...... abolic disorders and fibrosis.
@en
The new-generation pan-peroxis ...... abolic disorders and fibrosis.
@nl
P2093
P2860
P356
P1476
The new-generation pan-peroxis ...... abolic disorders and fibrosis.
@en
P2093
Alain Philippot
Céline Estivalet
Derek A Mann
Evelyne Defrêne
Fiona Oakley
Francine Kupkowski
Guillaume Wettstein
Ingrid Jantzen
Irena Konstantinova
Isabelle Leclercq
P2860
P304
P356
10.1002/HEP4.1057
P577
2017-06-19T00:00:00Z